Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.
Dalotto-Moreno T, Croci DO, Cerliani JP, Martinez-Allo VC, Dergan-Dylon S, Méndez-Huergo SP, Stupirski JC, Mazal D, Osinaga E, Toscano MA, Sundblad V, Rabinovich GA, Salatino M.
Dalotto-Moreno T, et al. Among authors: cerliani jp.
Cancer Res. 2013 Feb 1;73(3):1107-17. doi: 10.1158/0008-5472.CAN-12-2418. Epub 2012 Nov 29.
Cancer Res. 2013.
PMID: 23204230